Relating to the self-administration of prescription anti-seizure medicine by a student at a public school.
Impact
The bill mandates that students diagnosed with a seizure disorder be allowed to possess and self-administer their prescribed anti-seizure medication on school property or during school-related events. Key requirements laid out in the bill include the necessity for parental written authorization, as well as confirmation from a physician verifying the student's capability and outlining the prescribed medication's details. This framework aims to ensure that students can act independently regarding their health needs while also maintaining compliance with medical guidelines.
Summary
House Bill 1807, introduced by Representative Goodwin, addresses the self-administration of prescription anti-seizure medication by students in public schools. The bill amends the Education Code, specifically Section 38.015, to include provisions for students with seizure disorders, thus expanding the existing allowances for self-administration of asthma and anaphylaxis medications. This legislative move seeks to empower students to manage their health conditions independently while ensuring safety in the school environment.
Contention
While HB 1807 is primarily seen as a positive step towards facilitating the health management of affected students, there may be points of contention regarding the implementation of self-administration protocols. Parents and educators may have differing opinions on the level of responsibility to be placed on students, especially younger ones, when managing prescription medications. Additionally, ensuring that all stakeholders, including school nurses and staff, are adequately trained to support these provisions could pose challenges that might need to be addressed through further legislative measures or regulations.
Relating to the maintenance, administration, and disposal of opioid antagonists on public and private school campuses and to the permissible uses of money appropriated to a state agency from the opioid abatement account.
Relating to the use of epinephrine auto-injectors and medication designated for treatment of respiratory distress on public and private school campuses.
Relating to the use of opioid antagonists on the campuses of public and private schools and institutions of higher education and at or in transit to or from off-campus school events.
Relating to the maintenance, administration, and disposal of opioid antagonists on public and private school campuses and to the permissible uses of money appropriated to a state agency from the opioid abatement account.
Relating to discipline of public school students who fail to report possession or use of prescription medication on or near school premises, at school or school-related activities, or on a school bus.